Prahem Laboratories LLP

Mycophenolate Mofetil Tablets 500 mg are an immunosuppressive medication used to prevent rejection in patients who have undergone kidney, heart, or liver transplantation. The medicine works by suppressing the activity of the immune system and reducing the likelihood of the body attacking the transplanted organ.
Commonly used alongside other immunosuppressants, this formulation ensures effective and long-term graft survival. It should only be taken under strict medical supervision due to its potent immune-modulating effects.

Mycophenolate Mofetil Tablets 500 mg are an immunosuppressive medication used to prevent rejection in patients who have undergone kidney, heart, or liver transplantation. The medicine works by suppressing the activity of the immune system and reducing the likelihood of the body attacking the transplanted organ.
Commonly used alongside other immunosuppressants, this formulation ensures effective and long-term graft survival. It should only be taken under strict medical supervision due to its potent immune-modulating effects.

Mycophenolate Mofetil 500mg Tablets (Concord) are an immunosuppressant formulation designed to help prevent acute organ rejection in transplant patients. The medication works by inhibiting purine synthesis in lymphocytes, thereby reducing immune system activity and preventing the body from attacking the transplanted organ.

The 500mg strength is commonly prescribed as part of combination therapy with other immunosuppressive agents such as corticosteroids or calcineurin inhibitors. Box packaging ensures safe storage, easy dispensing, and suitability for hospital, pharmacy, and long-term therapy use.